The South African Health Products Regulatory Authority (SAHPRA) participated in the fifth edition of 2024 South African Pharmaceutical Exhibition (SAPHEX) / The Pharmacy Show (TPS) during 13-14 March 2024, at the Sandton Convention Centre in Johannesburg....
Pretoria, 06 November 2023 – The South African Health Products Regulatory Authority (SAHPRA) is urging patients, doctors, nurses, or pharmacists to play their part in reporting side effects using the MedSafety app. Reporting side effects is key to helping make medicines safer for the population...
The South African Health Products Regulatory Authority (SAHPRA) is commemorating the #MedSafetyWeek2023 campaign, in collaboration with South African Pharmacy Council (SAPC), by hosting a webinar focused on the Importance of Reporting Adverse Events. The #MedSafetyWeek is an international social media campaign organised every year by the Uppsala Monitoring...
23 April 2021 Post Importation Testing Exemptions (PITE) granted due to COVID-19 pandemic Post importation testing exemption approvals granted since March 2020 due to the Covid-19 pandemic, are extended to 30 September 2021 without further need of an application thereof. The initial approval date was extended to...
22 April 2021 SAHPRA is pleased to announce the launch of the Med Safety App. The Med Safety App is a mobile application (App) that is designed to simplify and promote the reporting of suspected adverse drug reactions (ADRs), including adverse events following immunisation (AEFIs) by...
The document in the link below has been prepared to serve as a guideline to healthcare professionals, reporting adverse drug reactions and product quality problems. It represents South African Health Products Regulatory Authority’s (SAHPRA’s) current thinking on the safety, quality and efficacy of medicines (including...
